Epigenetic changes of ovarian cancer-initiating cells remain unexplored. In this study, we aimed to discover novel DNA methylation in ovarian cancer initiation cells and tested its potential as a prognostic biomarker.
Lai, H., Liao, Y., & Huang, R. (2013). Methylomic profiling of ovarian cancer-initiating cells identifies DNA methylation as a prognostic biomarker. Gynecologic Oncology, 130(1), e133-e134. https://doi.org/10.1016/j.ygyno.2013.04.381